66 results
8-K
EX-10.2
bz4 5s4e70qk
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
7c7s3
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
m8y57 1p5l6v6c10qk
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-10.1
t7clf x1zdx6ow0j3
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
y6j03
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-4.4
2ooe8ib
9 Nov 22
Shelf registration
4:15pm
S-3
ltnj4rz5 unxbn8rcdg
9 Nov 22
Shelf registration
4:15pm